Premium
Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma
Author(s) -
Rigaud Charlotte,
Abbou Samuel,
MinardColin Véronique,
Geoerger Birgit,
Scoazec Jean Yves,
Vassal Gilles,
Jaff Nabaz,
Heuberger Laurence,
ValteauCouanet Dominique,
Brugieres Laurence
Publication year - 2018
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.26902
Subject(s) - medicine , nivolumab , anaplastic large cell lymphoma , anaplastic lymphoma kinase , refractory (planetary science) , oncology , lymphoma , cancer research , immunotherapy , cancer , malignant pleural effusion , lung cancer , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom